06.04.2016
- What a difference a day makes. On Apr. 3, European time, Pfizer and Allergan said the US Federal Trade Commission’s deeper probe into their potential merger, the so-called second...
19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...
21.02.2014
- Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...
26.08.2013
- Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...
01.07.2013
- Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...
20.05.2013
- Generic drugmaker Actavis, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott for $5 billion in stock. The companies...
31.01.2013
- Endo Health Solutions has held talks in recent weeks with drugmakers potentially interested in buying the maker of pain relief medication, people familiar with the matter said on...
20.08.2012
- Warner Chilcott said German drugmaker Bayer filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a...
